An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)
NCT07220603
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Myotonic Dystrophy 1
Interventions
DRUG:
PGN-EDODM1
Sponsor
PepGen Inc